Ann: Quarterly Activities Report and Appendix 4C, page-3

To quote the Fonz, yepamundo. Having spoken to Justyn on a few occasions, he states that they're actively trying to address ASX issues, but does not mention what they are when asked. Further given Jitto has form in having companies for which he is CEO de-listed via the two year suspension route, this is a possible aim - what's the benefit? I presume that assets then go to whoever is left standing, which will be Medigen and associates as the major shareholders; with profits from sales in the meantime also going to Medigen via the inter-company trading. It's also interesting that profits equal exactly the costs that Medigen charge for materials and costs. It's the usual not ethical but legal situation...TDL/TBG small holders end up with nothing.